# The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses

> **NCT00786994** · PHASE2 · COMPLETED · sponsor: **Birken AG** · enrollment: 165 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** Oleogel-S10 100 mg/g
- **DRUG:** Placebo (petroleum jelly)

## Key facts

- **NCT ID:** NCT00786994
- **Lead sponsor:** Birken AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2015-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00786994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00786994, "The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00786994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*